US4435393A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Derivatives of 10-(1-azabicyclo[2.2.2]oct-3-yl)-N,N dimethyl-10H-phenothiazine-2-sulfonamide as medicaments
Assignee: Pharmindustrie
•
Filing: 1982-03-22
•
Granted: 1984-03-06
•
Expires: 2002-03-22
Abstract
Abstract Compounds of the general formula: <IMAGE> (I) in which either X represents an atom of sulfur and Y represents the N-oxide group or X represents the sulfinyl group or the sulfonyl group and Y represents an atom of nitrogen or the N-oxide group and their salts of addition with mineral or organic acids, their process of preparation and their use as a medicament for the treatment of gastric and duodenal ulcers.
Inventors
- 👤 Marie-Christine Dubroeucq
- 👤 Jean E. M. A. Rataud
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-11-04 07:22
CPC Classifications
C; C07; C07D; C07D453/00; C07D453/02; A; A61; A61P; A61P1/00; A61P1/04
Claims Analysis
Total Claims: 5
Claim 1
Independent Claim
78 words
A process for treating a human suffering from duodenal and gastric ulcers which comprises orally administering to said human 50 to 500 mg per day of a compound of the formula ##STR5## in which either X represents an atom of sulfur and Y represents the N-oxide group, or X represents the sulfinyl group or the sulfonyl group and Y represents an atom of nitrogen or the N-oxide group, or its salt of addition with a pharmaceutically acceptable acid.
Claim 2
Dependent Claim
78 words
A process for treating a human suffering from duodenal and gastric ulcers which comprises orally administering to said human 50 to 500 mg per day of a compound of the formula ##STR5## in which either X represents an atom of sulfur and Y represents the N-oxide group, or X represents the sulfinyl group or the sulfonyl group and Y represents an atom of nitrogen or the N-oxide group, or its salt of addition with a pharmaceutically acceptable acid.
Claim 3
Dependent Claim
27 words
The process according to claim 1 wherein the compound is administered in the form of a tablet, capsule, gelatin coated capsule, suppository or injestible or injectable solution.
Claim 4
Dependent Claim
35 words
The process according to claim 1 wherein in said compound X represents the sulfinyl group and Y represents an atom of nitrogen or the N-oxide group in the form of their racemic or enantiomer diastereoisomers.
Claim 5
Dependent Claim
27 words
The process according to claim 3 wherein the compound is administered in the form of a tablet, capsule, gelatin coated capsule, suppository or injestible or injectable solution.
References Cited (Backward Citations)
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1987-03-06 | 1987-09-05 | 1988-03-06 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1991-03-06 | 1991-09-05 | 1992-03-06 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 1995-03-06 | 1995-09-05 | 1996-03-06 | $7700.00 | Window Closed / Lapsed |